A
Alison Hall
Researcher at University of Cambridge
Publications - 32
Citations - 1586
Alison Hall is an academic researcher from University of Cambridge. The author has contributed to research in topics: Genetic testing & Population. The author has an hindex of 19, co-authored 32 publications receiving 1326 citations.
Papers
More filters
Journal ArticleDOI
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening
Wybo Dondorp,Guido de Wert,Yvonne Bombard,Diana W. Bianchi,Carsten Bergmann,Pascal Borry,Lyn S. Chitty,Florence Fellmann,Francesca Forzano,Alison Hall,Lidewij Henneman,Heidi Carmen Howard,Anneke Lucassen,Kelly E. Ormond,Borut Peterlin,Dragica Radojkovic,Wolf Rogowski,Maria Soller,Aad Tibben,Lisbeth Tranebjærg,Lisbeth Tranebjærg,Carla G. van El,Martina C. Cornel +22 more
TL;DR: This document argues for a cautious expansion of the scope of prenatal screening to serious congenital and childhood disorders, only following sound validation studies and a comprehensive evaluation of all relevant aspects.
Journal ArticleDOI
Responsible implementation of expanded carrier screening
Lidewij Henneman,Pascal Borry,Davit Chokoshvili,Davit Chokoshvili,Martina C. Cornel,Carla G. van El,Francesca Forzano,Alison Hall,Heidi Carmen Howard,Sandra Janssens,Hülya Kayserili,Phillis Lakeman,Anneke Lucassen,Sylvia A Metcalfe,Lovro Vidmar,Guido de Wert,Wybo Dondorp,Borut Peterlin +17 more
TL;DR: The challenges that expanded carrier screening might pose in the context of the lessons learnt from decades of population-based carrier screening and in thecontext of existing screening criteria are discussed.
Journal ArticleDOI
Public health implications from COGS and potential for risk stratification and screening
TL;DR: Implementing risk-stratified prevention for breast and prostate cancers would require attention to the use and storage of genetic information, the development of risk assessment tools, new protocols for consent and programs of professional education and public engagement.
Journal ArticleDOI
Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine?
Wylie Burke,Hilary Burton,Alison Hall,Mohamed A. Karmali,Muin J. Khoury,Bartha Maria Knoppers,Eric M. Meslin,Fiona J. Stanley,Caroline F. Wright,Ronald L. Zimmern +9 more
TL;DR: An international multidisciplinary meeting was held in May 2010 in Ickworth, United Kingdom, with the aim of setting an agenda for the development of public health in an era of genome-based and “personalized” medicine, suggesting a need to reconfigure both the focus for existing genomic research and the stage at which funding is targeted.
Journal ArticleDOI
'Personalized medicine': what's in a name?
TL;DR: It is suggested that although genomics and molecular biosciences will undoubtedly greatly enhance the power of medicine, they will not lead to a conceptually new paradigm of medical care.